Evaluation of CAP@CS nanoparticles infused cellulose acetate membrane and their invitro antidiabetic, anticancer and antibacterial activity

•The CAP@CS nanoparticles were synthesized using an ionic gelation technique.•Characterization of the cellulose acetate membrane loaded with CAP@CS nanoparticles.•Nanoparticles containing CAP and CS were successfully synthesized, and their anticancer, antidiabetic, and antibacterial efficacy was dem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surfaces and interfaces 2023-08, Vol.40, p.103009, Article 103009
Hauptverfasser: Narmadha, R., Siranjeevi, R., Kannan, M., Kala, K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•The CAP@CS nanoparticles were synthesized using an ionic gelation technique.•Characterization of the cellulose acetate membrane loaded with CAP@CS nanoparticles.•Nanoparticles containing CAP and CS were successfully synthesized, and their anticancer, antidiabetic, and antibacterial efficacy was demonstrated invitro studies. Cancer drugs with pharmacological activity can be found in many different natural sources. Invitro and invivo research have shown that capsaicin incorporated chitosan nanoparticles (CAP@CS) have anticancer properties. CAP's medicinal potential is limited by its poor water solubility and bioavailability. This research presents the synthesis and characterization of CAP@CS nanoparticles encapsulated in a cellulose acetate membrane (CAP@CS/CA) for potential use in cancer therapy and the treatment of diabetes. The synthesized CAP@CS/CA membrane was analyzed using Scanning Electron Microscopy, Thermogravimetric analysis, mechanical strength testing, and drug release studies. Renal cell carcinoma (ACHN) cancer cell lines were used to test the efficacy of the synthesized CAP@CS/CA membrane in inhibiting tumor growth. These findings point to the synthesized CAP@CS/CA membrane as a potential new therapeutic agent for treating skin cancer and for its antibacterial properties. The capacity of the CAP@CS/CA membrane to inhibit carbohydrate digesting enzymes such a-amylase with IC50 values as low as 62.5 mg/mL−1 demonstrates its antidiabetic efficacy. We conclude that the CAP@CS/CA membrane has promising potential antidiabetic potential against important diabetes enzymes and is a perfect nanomedicine for nano-biomedical applications. [Display omitted]
ISSN:2468-0230
2468-0230
DOI:10.1016/j.surfin.2023.103009